Hathcock K S, Laszlo G, Pucillo C, Linsley P, Hodes R J
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
J Exp Med. 1994 Aug 1;180(2):631-40. doi: 10.1084/jem.180.2.631.
Antigen-specific T cell activation requires the engagement of the T cell receptor (TCR) with antigen as well as the engagement of appropriate costimulatory molecules. The most extensively characterized pathway of costimulation has been that involving the interaction of CD28 and CTLA4 on the T cell with B7 (now termed B7-1) on antigen presenting cells. Recently, B7-2 a second costimulatory ligand for CTLA4, was described, demonstrating the potential complexity of costimulatory interactions. This report examines and compares the expression and function of B7-1 and B7-2. Overall these results indicate that (a) B7-1 and B7-2 can be expressed by multiple cell types, including B cells, T cells, macrophages, and dendritic cells, all of which are therefore candidate populations for delivering costimulatory signals mediated by these molecules; (b) stimulating B cells with either LPS or anti-IgD-dextran induced expression of both B7-1 and B7-2, and peak expression of both costimulatory molecules occurred after 18-42 h of culture. Expression of B7-2 on these B cell populations was significantly higher than expression of B7-1 at all times assayed after stimulation; (c) blocking of B7-2 costimulatory activity inhibited TCR-dependent T cell proliferation and cytokine production, without affecting early consequences of TCR signaling such as induction of CD69 or interleukin 2 receptor alpha (IL-2R alpha); and (d) expression of B7-1 and of B7-2 can be regulated by a variety of stimuli. Moreover, expression of B7-1 and B7-2 can be independently regulated by the same stimulus, providing an additional complexity in the mechanisms available for regulating costimulation and hence immune response.
抗原特异性T细胞激活需要T细胞受体(TCR)与抗原结合,以及适当共刺激分子的结合。最广泛表征的共刺激途径涉及T细胞上的CD28和CTLA4与抗原呈递细胞上的B7(现称为B7-1)相互作用。最近,发现了CTLA4的第二种共刺激配体B7-2,这表明共刺激相互作用可能具有复杂性。本报告研究并比较了B7-1和B7-2的表达及功能。总体而言,这些结果表明:(a)B7-1和B7-2可由多种细胞类型表达,包括B细胞、T细胞、巨噬细胞和树突状细胞,因此所有这些细胞类型都是传递由这些分子介导的共刺激信号的候选群体;(b)用LPS或抗IgD-葡聚糖刺激B细胞可诱导B7-1和B7-2的表达,两种共刺激分子的峰值表达出现在培养18-42小时后。在刺激后的所有检测时间点,这些B细胞群体上B7-2的表达均显著高于B7-1的表达;(c)阻断B7-2共刺激活性可抑制TCR依赖性T细胞增殖和细胞因子产生,而不影响TCR信号传导的早期后果,如CD69或白细胞介素2受体α(IL-2Rα)的诱导;(d)B7-1和B7-2的表达可受多种刺激调节。此外,B7-1和B7-2的表达可由相同刺激独立调节,这为调节共刺激及免疫反应的机制增添了额外的复杂性。